C. Mehlman

Ceritinib ALK T1151R Resistance Mutation in Lung Cancer With Initial Response to Brigatinib.

J. Cadranel, K. Kerrou, R. Lacave, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer

J. Emile, T. Chinet, A. Costantini, 2021, Cancers.

Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study.

N. Girard, H. Blons, J. Trédaniel, 2019, Lung cancer.

Surfaces and equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the emergency department at a university hospital

É. Oksenhendler, C. Delaugerre, B. Plaud, 2020, International Journal of Hygiene and Environmental Health.

Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports

F. Coulet, J. Cadranel, R. Lacave, 2023, Frontiers in Oncology.